Skip to main content
. 2014 Sep 14;20(34):12202–12211. doi: 10.3748/wjg.v20.i34.12202

Table 3.

Univariate analysis of β-actin immunostaining with clinicopathological parameters n (%)

Clinicopathological parameters Groups Epithelial cells (total IHC score) Inflammatory cells (total IHC score) Epithelial + Inflammatory cells (avg. total IHC score)
P value P value P value
Age (yr)
≤ 50 11 (42) 0.49331 0.27241 0.29411
> 50 15 (58)
Sex
Male 20 (77) 0.97211 0.27241 0.52751
Female 6 (23)
Tumor grade
WD 0 (0) 0.60892 0.01682 0.83932
MD 4 (15)
PD 14 (54)
Mucinous 0 (0)
SRC 8 (31)
Depth of invasion3
T1 2 (8) 0.54462 0.66182 0.88042
T2 2 (8)
T3 13 (52)
T4 8 (32)
Lymph Node status3
N0 6 (24) 0.75102 0.62932 0.54262
N1 8 (32)
N2 8 (32)
N3 3 (12)
Treatment Modality3
Surgery 14 (56) 0.35421 0.81351 0.29101
NACT + surgery 11 (44)
1

Mann Whitney Test;

2

Kruskal Wallis Test;

3

TNM staging and Treatment modality information was available for only 25 (out of 26) patients. P < 0.05 indicates statistically significant difference. IHC: Immunohistochemistry; MD: Moderately differentiated; PD: Poorly differentiated; SRC: Signet ring cell carcinoma.